ProfileGDS5822 / ILMN_2437867
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 73% 79% 73% 78% 76% 77% 80% 78% 75% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 16773
GSM1276600PDAC Late Ablation Control 2129.179
GSM1276601PDAC Late Ablation Control 397.573
GSM1276602PDAC Late Ablation 1112.178
GSM1276603PDAC Late Ablation 2101.276
GSM1276604PDAC Late Ablation 311777
GSM1303940PDAC Late Ablation_anti-CTLA4 1127.480
GSM1303941PDAC Late Ablation_anti-CTLA4 2150.578
GSM1303942PDAC Late Ablation_anti-CTLA4 3115.175